von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo - Concepedia

Concepedia

Publication | Closed Access

von Willebrand Factor Predicts Mortality in ACS Patients Treated with Potent P2Y12 Antagonists and is Inhibited by Aptamer BT200 Ex Vivo

14

Citations

48

References

2020

Year

Katarina D. Kovacevic, Bernd Jilma, Shuhao Zhu, James C. Gilbert, Max‐Paul Winter, Aurel Toma, Christian Hengstenberg, Iréne Lang, Jacek Kubica, Jolanta M. Siller‐Matula

Thrombosis and Haemostasis

Abstract

VWF is a predictor of all-cause mortality in ACS patients under contemporary potent P2Y12 inhibitor therapy. BT200 effectively inhibited VWF activity in a target concentration-dependent manner.

References

	Year	Citations

Page 1